谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Phase 2 Study (distinguish) of DKN-01 in Combination with Tislelizumab + Chemotherapy As First-Line (1L) Therapy in Patients with Advanced Gastric or GEJ Adenocarcinoma (GEA).

Samuel J. Klempner, Bassam,Zev A. Wainberg,Hope Elizabeth Uronis,Vi Kien Chiu,Aaron James Scott,Syma Iqbal,Mohamedtaki Abdulaziz Tejani, Melissa C. Stilian, Mathis Thoma,Michael Kagey,Jason Baum,Cynthia A. Sirard,Rachel A. Altura,Jaffer A. Ajani

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用 0|浏览43
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要